Onlymyhealth on MSN
FISH test in cancer diagnosis – what it detects and how accurate it is
Cancer care has changed a lot in recent years. Doctors do not just look at how a tumour looks under a microscope. They also ...
Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients With Metastatic Colorectal Cancer Testing was performed ...
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma Human epidermal growth factor 2 (HER2/ERBB2) has ...
ASCO Exploring Broader Enhertu Use, Confirming Tumor-Agnostic Benefit of Tafinalr, Mekinist in TAPUR
The platform trial will add new arms testing Enhertu in solid tumors with HER2 amplification and gather data on Tafinlar-Mekinist's tissue-agnostic benefit for regular approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results